Prototype safely
Ideas are tested in bounded sandboxes using approved tools, explicit ownership, controlled budgets and non-patient or otherwise permitted data.
How We Work
Fast AI delivery, controlled by evidence.
Drexing uses an agentic delivery model to move from workflow ideas to governed, supportable AI capabilities without relying on informal prompts or unverified output.
The operating principle is simple: move quickly, but only promote work when the evidence, controls, ownership and human review points are clear.
01
Discover
Find a real workflow pressure, user need or operational bottleneck.
02
Specify
Define boundaries, risks, human control points and acceptance criteria.
03
Build
Deliver small slices across workflow, UI, AI behaviour, audit and integration.
04
Evidence
Test, review and validate before release confidence becomes production authority.
05
Operate
Monitor adoption, quality, safety, cost, support load and improvement signals.
Operating model
Three lanes keep experimentation separate from production.
The model allows fast exploration, but prevents prototypes from quietly becoming live clinical or operational workflows without explicit promotion.
Build with controls
Promoted work becomes a defined use case with design artefacts, acceptance criteria, evidence gates, reviews and delivery ownership.
Scale only when proven
Released capabilities are monitored for quality, adoption, safety, cost, support readiness and residual risk before wider rollout.
Delivery rhythm
Every AI workflow follows a controlled path.
The point is not heavy process. The point is to make sure speed, safety and accountability travel together from idea to live operation.
IdeaCapture the opportunity
Workflow pain, user need or operational friction.
SpecDefine the contract
Actors, boundaries, risks, controls and evidence.
PlanSlice the work
Small increments with owners and dependencies.
BuildImplement safely
Workflow, UI, AI behaviour, audit and integrations.
TestProve behaviour
Functional, safety, clinical and regression checks.
ReviewChallenge the result
Code, privacy, governance, UX and operating cost.
ObserveMeasure in use
Adoption, quality, retries, cost and improvement signals.
Evidence gates
Production release is gated by proof, not confidence.
Each use case must show that the problem is real, the boundary is clear, the human control point is known, and the workflow can be supported after release.
Clear use-case contract
The team defines who the workflow helps, what it does, what it does not do, what data it needs and where judgement remains human-led.
Reviewed evidence
Tests, clinical assumptions, privacy controls, audit events, user experience and runtime cost are reviewed before the workflow is shipped.
Measured operation
Scale depends on adoption quality, reliability, safety signals, support load, cost discipline and visible improvement over the baseline.
Simple framing: prototypes are for learning; governed delivery is for building; controlled operation is for scaling.
Governance rules
AI assistance stays observable, reviewable and accountable.
Drexing’s delivery model is designed for high-trust workflows where clinical safety, privacy, cost and operational resilience matter.
No informal prompt becomes production.
Every material workflow needs a defined use case, acceptance criteria, review path and evidence trail.
Human control remains explicit.
Clinical and material operational outcomes retain review, approval, override and escalation points.
AI cost and usage are managed.
Model routing, context budgets, retries, usage attribution and margin impact are part of the operating model.
Scaling waits for evidence.
Adoption alone is not enough. Quality, safety, support readiness and runtime economics must hold.